Outcome of Allogeneic Hematopoietic Stem Cell Transplantation
Recruiting
Observational Study
Hematopoietic Stem Cell Transplant (HSCT)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,000 (estimated)
- Sponsor
- The University of Hong Kong · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
To collect baseline and outcome data relating to all bone marrow, peripheral blood, cord blood hematopoietic stem cell transplants and therapies related to hematopoietic stem cell transplantation performed in Queen Mary Hospital.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patients aged 18 years or older who received allogeneic hematopoietic stem cell transplantation (allo-HSCT).
Exclusion Criteria:
* participant who is unable to give informed consent in a prospective cohort.
Contacts